comparemela.com

Latest Breaking News On - Medicinova inc - Page 1 : comparemela.com

MediciNova Announces Two Poster Presentations at the 92nd EAS Congress 2024, the Annual Meeting of the European Atherosclerosis Society Regarding the Use of MN-001 (Tipelukast) for Cardiometabolic Conditions

Medicinova Announces Two Poster Presentations At The 92Nd EAS Congress 2024, The Annual Meeting Of The European Atherosclerosis Society Regarding The

MediciNova (NASDAQ:MNOV) Now Covered by Analysts at StockNews com

StockNews.com assumed coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a report released on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. MediciNova Price Performance NASDAQ:MNOV opened at $1.34 on Thursday. The company has a 50 day moving average price of $1.41 and a 200-day moving average price […]

MediciNova (NASDAQ:MNOV) Now Covered by StockNews com

StockNews.com began coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a report published on Thursday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. MediciNova Stock Down 0.7 % MNOV opened at $1.34 on Thursday. The firm has a market cap of $65.73 million, a P/E ratio of -7.88 and […]

MediciNova (NASDAQ:MNOV) Coverage Initiated at StockNews com

Investment analysts at StockNews.com started coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a report issued on Thursday. The firm set a “hold” rating on the biopharmaceutical company’s stock. MediciNova Price Performance MNOV stock opened at $1.34 on Thursday. The firm has a market capitalization of $65.73 million, a P/E ratio of […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.